A detailed history of New York State Teachers Retirement System transactions in Incyte Corp stock. As of the latest transaction made, New York State Teachers Retirement System holds 173,895 shares of INCY stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
173,895
Previous 211,984 17.97%
Holding current value
$12.4 Million
Previous $12.9 Million 10.55%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$57.33 - $68.61 $2.18 Million - $2.61 Million
-38,089 Reduced 17.97%
173,895 $11.5 Million
Q2 2024

Jul 24, 2024

BUY
$51.18 - $63.75 $426,585 - $531,356
8,335 Added 4.09%
211,984 $12.9 Million
Q1 2024

Apr 25, 2024

BUY
$56.55 - $66.59 $211,440 - $248,980
3,739 Added 1.87%
203,649 $11.6 Million
Q4 2023

Jan 24, 2024

SELL
$52.16 - $64.19 $48,508 - $59,696
-930 Reduced 0.46%
199,910 $12.6 Million
Q3 2023

Oct 25, 2023

SELL
$57.77 - $65.93 $425,822 - $485,970
-7,371 Reduced 3.54%
200,840 $11.6 Million
Q2 2023

Jul 27, 2023

SELL
$60.95 - $75.51 $848,241 - $1.05 Million
-13,917 Reduced 6.27%
208,211 $13 Million
Q1 2023

Apr 27, 2023

SELL
$70.23 - $86.01 $277,338 - $339,653
-3,949 Reduced 1.75%
222,128 $16.1 Million
Q4 2022

Jan 27, 2023

SELL
$67.18 - $84.11 $1.03 Million - $1.29 Million
-15,367 Reduced 6.36%
226,077 $18.2 Million
Q3 2022

Oct 28, 2022

SELL
$66.18 - $82.86 $658,226 - $824,125
-9,946 Reduced 3.96%
241,444 $16.1 Million
Q2 2022

Aug 01, 2022

BUY
$66.18 - $83.18 $7,345 - $9,232
111 Added 0.04%
251,390 $19.1 Million
Q1 2022

Apr 27, 2022

BUY
$66.02 - $79.71 $1.23 Million - $1.49 Million
18,660 Added 8.02%
251,279 $20 Million
Q4 2021

Jan 24, 2022

SELL
$63.34 - $74.11 $168,991 - $197,725
-2,668 Reduced 1.13%
232,619 $17.1 Million
Q3 2021

Oct 25, 2021

SELL
$68.67 - $84.02 $188,293 - $230,382
-2,742 Reduced 1.15%
235,287 $16.2 Million
Q2 2021

Jul 21, 2021

SELL
$79.87 - $87.53 $255,264 - $279,745
-3,196 Reduced 1.32%
238,029 $20 Million
Q1 2021

Apr 22, 2021

SELL
$76.02 - $100.5 $391,883 - $518,077
-5,155 Reduced 2.09%
241,225 $19.6 Million
Q4 2020

Jan 25, 2021

BUY
$80.74 - $97.7 $1,291 - $1,563
16 Added 0.01%
246,380 $21.4 Million
Q3 2020

Nov 06, 2020

SELL
$85.07 - $109.69 $1.13 Million - $1.45 Million
-13,261 Reduced 5.11%
246,364 $0
Q2 2020

Jul 21, 2020

SELL
$74.18 - $108.93 $541,365 - $794,971
-7,298 Reduced 2.73%
259,625 $27 Million
Q1 2020

Apr 29, 2020

BUY
$63.18 - $85.97 $277,992 - $378,268
4,400 Added 1.68%
266,923 $19.5 Million
Q4 2019

Jan 24, 2020

BUY
$73.04 - $95.72 $936,153 - $1.23 Million
12,817 Added 5.13%
262,523 $22.9 Million
Q3 2019

Oct 24, 2019

BUY
$72.82 - $86.52 $133,406 - $158,504
1,832 Added 0.74%
249,706 $18.5 Million
Q2 2019

Jul 18, 2019

SELL
$73.52 - $88.7 $57,345 - $69,186
-780 Reduced 0.31%
247,874 $21.1 Million
Q1 2019

May 07, 2019

BUY
$63.56 - $88.17 $4,067 - $5,642
64 Added 0.03%
248,654 $21.4 Million
Q4 2018

Jan 28, 2019

BUY
$58.5 - $69.94 $702 - $839
12 Added 0.0%
248,590 $15.8 Million
Q3 2018

Nov 02, 2018

BUY
$61.75 - $74.23 $1,914 - $2,301
31 Added 0.01%
248,578 $17.2 Million
Q2 2018

Aug 01, 2018

BUY
$60.85 - $83.98 $973 - $1,343
16 Added 0.01%
248,547 $16.7 Million
Q1 2018

May 01, 2018

SELL
$83.06 - $100.98 $288,052 - $350,198
-3,468 Reduced 1.38%
248,531 $20.7 Million
Q4 2017

Feb 12, 2018

SELL
$93.56 - $116.6 $367,316 - $457,771
-3,926 Reduced 1.53%
251,999 $23.9 Million
Q3 2017

Oct 30, 2017

SELL
$109.15 - $138.27 $125,740 - $159,287
-1,152 Reduced 0.45%
255,925 $29.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
257,077
257,077 $32.4 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.